✦ LIBER ✦

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer

✍ Scribed by Nemunaitis, J; Jahan, T; Ross, H; Sterman, D; Richards, D; Fox, B; Jablons, D; Aimi, J; Lin, A; Hege, K

Book ID: 110019322
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 170 KB
Volume: 13
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700922

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of Belagenpumatucel-L, a

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

✍ Nemunaitis, J; Nemunaitis, M; Senzer, N; Snitz, P; Bedell, C; Kumar, P; Pappen, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

A phase I trial of adoptive transfer of

A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer

✍ Eleni G. Iliopoulou; Panteleimon Kountourakis; Michalis V. Karamouzis; Dimitrios 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 259 KB

A phase II clinical trial of celecoxib c

A phase II clinical trial of celecoxib combined with platinum-based regimen as first-line chemotherapy for advanced non-small cell lung cancer patients with cyclooxygenase-2 positive expression

✍ Jun Zhao; Zhi-jie Wang; Jian-chun Duan; Qing-zhi Guo; Hua Bai; Lu Yang; Tong-ton 📂 Article 📅 2009 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 521 KB

A Phase I Trial of Cisplatin Plus Decita

A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer

✍ G. Schwartsmann; H. Schunemann; C.N.F. Gorini; A.F. Ferreira Filho; C. Garbino; 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 76 KB

Multicenter phase II trial of accelerate

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)

✍ Phernambucq, E C J; Biesma, B; Smit, E F; Paul, M A; Tol, A vd; Schramel, F M; B 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB